ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma, Inc. (AVBP) is a healthcare company (biotechnology) based in the United States. The share price is $11.12, down 3.85% on the day, which values the company at $574.9M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$11.12−3.85% today
Market value
$574.9M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ArriVent BioPharma, Inc. in more detail

AVBP trades at -3.1× next year's expected earnings, 115.0× sales.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

1 of the superinvestors tracked here hold AVBP, including Zhang Lei (16.4% of the portfolio).

Superinvestors holding AVBP

1 of the investors tracked here report a position in their latest 13F filing.

ArriVent BioPharma, Inc. (AVBP): questions and answers

What is ArriVent BioPharma, Inc.'s market cap?

ArriVent BioPharma, Inc. is valued at $574.9M at a share price of $11.12.

Does AVBP pay a dividend?

ArriVent BioPharma, Inc. does not currently pay a regular dividend.

Which famous investors own AVBP?

In their latest quarterly filings, Zhang Lei (16.4% of the portfolio) hold AVBP. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

When does ArriVent BioPharma, Inc. report earnings next?

ArriVent BioPharma, Inc.'s next earnings report is expected on November 16, 2026. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “ArriVent BioPharma, Inc. (AVBP) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AVBP

Underlying data: Yahoo Finance; company filings with the SEC.